Newstral
Article
South China Morning Post on 2022-04-16 16:58
Coronavirus: Hong Kong approves clinical trials for 3 Chinese vaccines targeting Omicron
Related news
- China approves 2 experimental COVID-19 vaccines to enter clinical trialsThe Jerusalem Post (JPost.com)
- China approves two coronavirus vaccines for human trialsAl Jazeera
- SChina approves CSPC, Cansino mRNA vaccines for clinical trial, boosting country’s arsenal against raging Omicron outbreakscmp.com
- China approves coronavirus vaccine for clinical trialsThe Jerusalem Post (JPost.com)
- COVID-19 vaccines now in phase 3 clinical trials — WHOvanguardngr.com
- Japanese firms launch domestic clinical trials for COVID-19 vaccinesThe Japan Times
- Drugmakers Have Set Speed Records in Devising Coronavirus Vaccines and Beginning Clinical Trialsclevescene.com
- NCOVID-19 vaccines near end of clinical trials, but distribution still a way offnomenugget.net
- Coronavirus: exempt emergency vaccines from late-stage clinical trials, Chinese health official urges WHOSouth China Morning Post
- Taiwan defends rush to buy 20 million doses of local vaccines still in clinical trialsSouth China Morning Post
- WChina approves new drug to treat Alzheimer’s; clinical trials planned for 2020 in USwraltechwire.com
- In clinical and real world trials, China’s Sinovac underperformsThe Economist
- China speeding up research into Covid-19 vaccines targeting Omicron variantSouth China Morning Post
- PChina approves experimental coronavirus vaccine trialspendect.com
- Cancer vaccines enter clinical trialsPhilly.com
- Coronavirus: Chinese firm says its vaccine candidate passes phase two clinical trialsSouth China Morning Post
- China says it has five coronavirus vaccines in human trialsThe Japan Times
- More covid-19 vaccines pass clinical trialsThe Economist
- Covaxin starts clinical trials, 375 people enrolledThe Times of India
- Turkey conducts clinical trials for Chinese vaccineHurriyet Daily News